These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 3839559

  • 1. Contrasting effects of 1,25-dihydroxyvitamin D3 on bone matrix and mineral appositional rates in the mouse.
    Marie PJ, Hott M, Garba MT.
    Metabolism; 1985 Aug; 34(8):777-83. PubMed ID: 3839559
    [Abstract] [Full Text] [Related]

  • 2. Continuous infusion of 1,25-dihydroxyvitamin D3 stimulates bone turnover in the normal young mouse.
    Marie PJ, Travers R.
    Calcif Tissue Int; 1983 Jul; 35(4-5):418-25. PubMed ID: 6688545
    [Abstract] [Full Text] [Related]

  • 3. Inhibition by aminohydroxypropylidene bisphosphonate (AHPrBP) of 1,25(OH)2 vitamin D3-induced stimulated bone turnover in the mouse.
    Marie PJ, Hott M, Garba MT.
    Calcif Tissue Int; 1985 May; 37(3):268-75. PubMed ID: 3926276
    [Abstract] [Full Text] [Related]

  • 4. Autoradiographic study of the effect of 1,25-dihydroxyvitamin D3 on bone matrix synthesis in vitamin D replete rats.
    Hock JM, Kream BE, Raisz LG.
    Calcif Tissue Int; 1982 Jul; 34(4):347-51. PubMed ID: 6814724
    [Abstract] [Full Text] [Related]

  • 5. Alkaline phosphatase inhibition by levamisole prevents 1,25-dihydroxyvitamin D3-stimulated bone mineralization in the mouse.
    Garba MT, Marie PJ.
    Calcif Tissue Int; 1986 May; 38(5):296-302. PubMed ID: 3087604
    [Abstract] [Full Text] [Related]

  • 6. Bone histomorphometry in 1,25(OH)2D3- and vitamin D3-treated aged laying hens.
    Newbrey JW, Truitt ST, Roland DA, Frost TJ, Untawale GG.
    Avian Dis; 1992 May; 36(3):700-6. PubMed ID: 1329713
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of bone matrix apposition by (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (AHPrBP) in the mouse.
    Marie PJ, Hott M, Garba MT.
    Bone; 1985 May; 6(3):193-200. PubMed ID: 4027097
    [Abstract] [Full Text] [Related]

  • 8. Response of rachitic rat bones to 1,25-dihydroxyvitamin D3: biphasic effects on mineralization and lack of effect on bone resorption.
    Gallagher JA, Beneton M, Harvey L, Lawson DE.
    Endocrinology; 1986 Oct; 119(4):1603-9. PubMed ID: 3757903
    [Abstract] [Full Text] [Related]

  • 9. Skeletal resistance to 1,25-dihydroxyvitamin D3 in osteopetrotic rats.
    Safadi FF, Hermey DC, Popoff SN, Seifert MF.
    Endocrine; 1999 Dec; 11(3):309-19. PubMed ID: 10786828
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. 1,25 Dihydroxyvitamin D3 modifies cyclosporine-induced bone loss.
    Epstein S, Schlosberg M, Fallon M, Thomas S, Movsowitz C, Ismail F.
    Calcif Tissue Int; 1990 Sep; 47(3):152-7. PubMed ID: 2224590
    [Abstract] [Full Text] [Related]

  • 12. Stimulation of undermineralized matrix formation by 1,25 dihydroxyvitamin D3 in long bones of rats.
    Hock JM, Gunness-Hey M, Poser J, Olson H, Bell NH, Raisz LG.
    Calcif Tissue Int; 1986 Feb; 38(2):79-86. PubMed ID: 3082498
    [Abstract] [Full Text] [Related]

  • 13. 24,25(OH)2D3, bone formation, and bone resorption in vitamin D-deficient, azotemic rats.
    Goodman WG, Baylink DJ, Sherrard DJ.
    Calcif Tissue Int; 1984 Mar; 36(2):206-13. PubMed ID: 6430503
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
    Staal A, Geertsma-Kleinekoort WM, Van Den Bemd GJ, Buurman CJ, Birkenhäger JC, Pols HA, Van Leeuwen JP.
    J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
    [Abstract] [Full Text] [Related]

  • 17. [Comparative study of the effect of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on calcium homeostasis and bone tissue state in rats during hypokinesia].
    Sergeev IN, Blazheevich NV, Kaplanskiĭ AS, Shvets VN, Belakovskiĭ MS.
    Vopr Med Khim; 1987 Jan; 33(1):100-7. PubMed ID: 3495067
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Exogenous 1,25-dihydroxyvitamin D3 exerts a skeletal anabolic effect and improves mineral ion homeostasis in mice that are homozygous for both the 1alpha-hydroxylase and parathyroid hormone null alleles.
    Xue Y, Karaplis AC, Hendy GN, Goltzman D, Miao D.
    Endocrinology; 2006 Oct; 147(10):4801-10. PubMed ID: 16857747
    [Abstract] [Full Text] [Related]

  • 20. Long term administration of prostaglandin inhibitors in vivo fail to influence cartilage and bone mineral metabolism in the rat.
    Boiskin I, Epstein S, Ismail F, Fallon MD, Levy W.
    Bone Miner; 1988 Apr; 4(1):27-36. PubMed ID: 3263891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.